Navigation Links
New study shows how nanotechnology can help detect disease earlier
Date:5/22/2012

LEXINGTON, KY. (May 21, 2012) A new study led by University of Kentucky researchers shows a new way to precisely detect a single chemical at extremely low concentrations and high contamination.

The study, published online for ACS Nano, was carried out in the laboratory of Peixuan Guo, the William S. Farish Endowed Chair in Nanobiotechnology at the University of Kentucky Markey Cancer Center. The study shows that the phi29 DNA packaging nanomotor connector can be used to sense chemicals with reactive thioesters or maleimide using single channel conduction assays based on three observable fingerprints. This channel system could be further developed into very sensitive sensing devices.

The ability to detect a chemical at a low concentration and high contamination is especially important for environmental surveillance, homeland security, athlete drug monitoring, toxin/drug screening, and earlier disease diagnosis.

In the case of disease diagnosis, the production of an unusual metabolic product is a feature of disease, but in early stages, the concentration of this product is very low. Single molecule detection will facilitate the early detection of disease such as cancer, so as to facilitate earlier treatment.

"Sensitivity of detection is a major challenge in the diagnosis of many diseases," said Guo. "Our next step is to find one metabolic product of one disease and determine the reality in earlier disease diagnosis."

"The proof-of-principle studies described in this study will be extended in the future to engineer multiple probes within a single pore for concurrent detection of multiple targets at the single molecule level in real time," said Farzin Haque, research assistant professor at the UK College of Pharmacy, and first author on the paper.


'/>"/>

Contact: Allison Perry
allison.perry@uky.edu
859-323-2399
University of Kentucky
Source:Eurekalert

Page: 1

Related biology news :

1. University of Leicester study finds low agreeableness linked to a preference for aggressive dogs
2. Squid ink from Jurassic period identical to modern squid ink, U.Va. study shows
3. Richer parasite diversity leads to healthier frogs, says University of Colorado study
4. Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals
5. New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean
6. Florida Tech biological sciences professor earns $257,000 NSF grant to study coral diseases
7. Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates
8. NIH-led study finds genetic test results do not trigger increased use of health services
9. Nottingham researchers lead worlds largest study into pre-eclampsia
10. USF study: Common fungicide wreaks havoc on freshwater ecosystems
11. Study sheds new light on importance of human breast milk ingredient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017 MedNet Solutions , ... the entire spectrum of clinical research, is proud ... year for the organization in terms of corporate ... eClinical products and services. The company,s exceptional achievements ... of iMedNet ™ ...
(Date:1/12/2017)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer ... it has signed agreements with seven strategic partners across ... Middle East for commercialization of the Trovera™ ... of international distribution agreements for Trovagene,s CLIA based liquid ... The initial partners will introduce Trovagene,s liquid biopsy tests ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
(Date:1/19/2017)... , Jan 19, 2017 Research and ... by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis ... ... forecasts that the global market is projected to reach $15,737 million ... 13% from 2016 to 2022. Omic technologies segment ...
(Date:1/19/2017)... -- Research and Markets ... has announced the addition of the "Implantable ... report to their offering. Report Highlights: ... a detailed analysis on current and future market trends to identify the ... values as the base numbers Key market trends across ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
Breaking Biology Technology: